<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35105721</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2053-8790</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Lupus science &amp; medicine</Title><ISOAbbreviation>Lupus Sci Med</ISOAbbreviation></Journal><ArticleTitle>Human leucocyte antigens profiling in Malay female patients with systemic lupus erythematosus: are we the same or different?</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e000554</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/lupus-2021-000554</ELocationID><Abstract><AbstractText Label="OBJECTIVE">SLE is a heterogeneous autoimmune disease, in terms of clinical presentation, incidence and severity across diverse ethnic populations. We investigated the human leucocyte antigens (HLA) profile (ie, HLA-A, HLA-B and HLA-C, HLA-DRB1, HLA-DQA1, HLA-DQB1, HLA-DPA1 and HLA-DPB1) in Malaysian Malay female patients with SLE and determined the generalisability of the published HLA risk factors across different ethnic populations globally including Malaysia.</AbstractText><AbstractText Label="METHODS">One hundred Malay female patients with SLE were recruited between January 2016 and October 2017 from a nephrology clinic. All patients were genotyped for HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DQA1, HLA-DQB1, HLA-DPA1 and HLA-DPB1 alleles using PCR sequence-specific oligonucleotides method on Luminex platform. A total of 951 HLA genotyped population-based Malay control subjects was used for association testing by means of OR with 95% CIs.</AbstractText><AbstractText Label="RESULTS">Our findings convincingly validated common associations between HLA-A*11 (OR=1.65, p=3.36&#xd7;10<sup>-3</sup>, corrected P (Pc)=4.03&#xd7;10<sup>-2</sup>) and DQB1*05:01 (OR=1.56, p=2.02&#xd7;10<sup>-2</sup>, Pc=non-significant) and SLE susceptibility in the Malay population. In contrast, DQB1*03:01 (OR=0.51, p=4.06&#xd7;10<sup>-4</sup>, Pc=6.50&#xd7;10<sup>-3</sup>) were associated with decreased risk of SLE in Malay population. Additionally, we also detected novel associations of susceptibility HLA genes (ie, HLA-B*38:02, DPA1*02:02, DPB1*14:01) and protective HLA genes (ie, DPA1*01:03). When comparing the current data with data from previously published studies from Caucasian, African and Asian populations, DRB1*15 alleles, DQB1*03:01 and DQA1*01:02 were corroborated as universal susceptibility and protective genes.</AbstractText><AbstractText Label="CONCLUSIONS">This study reveals multiple HLA alleles associated with susceptibility and protection against risk of developing SLE in Malay female population with renal disorders. In addition, the published data from different ethnic populations together with our study further support the notion that the genetic effects from association with DRB1*15:01/02, DQB1*03:01 and DQA1*01:02 alleles are generalised to multiple ethnic populations of Caucasian, African and Asian descents.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Selvaraja</LastName><ForeName>Malarvili</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Pharmaceutical Sciences, No 1, Jalan Gading, UCSI Heights, Taman Connaught, UCSI University, Cheras, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Microbiology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Too</LastName><ForeName>Chun Lai</ForeName><Initials>CL</Initials><Identifier Source="ORCID">0000-0002-4079-8454</Identifier><AffiliationInfo><Affiliation>Immunogenetic Unit, Allergy and Immunology Research Centre, Ministry of Health Malaysia, National Institutes of Health Complex, Institute for Medical Research, Shah Alam, Selangor, Malaysia toocl@moh.gov.my syafinaz@upm.edu.my.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Division of Rheumatology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Lay Kim</ForeName><Initials>LK</Initials><AffiliationInfo><Affiliation>Immunogenetic Unit, Allergy and Immunology Research Centre, Ministry of Health Malaysia, National Institutes of Health Complex, Institute for Medical Research, Shah Alam, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koay</LastName><ForeName>Bee Tee</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>Transplantation Immunology Unit, Allergy and Immunology Research Centre, Ministry of Health Malaysia, National Institutes of Health Complex, Institute for Medical Research, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdullah</LastName><ForeName>Maha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Anim Md</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arip</LastName><ForeName>Masita</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Allergy and Immunology Research Centre, Ministry of Health. National Institutes of Health Complex, Institute for Medical Research, Shah Alam, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amin-Nordin</LastName><ForeName>Syafinaz</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia toocl@moh.gov.my syafinaz@upm.edu.my.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus Sci Med</MedlineTA><NlmUniqueID>101633705</NlmUniqueID><ISSNLinking>2053-8790</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059811">HLA-DRB1 Chains</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian People</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059811" MajorTopicYN="N">HLA-DRB1 Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008296" MajorTopicYN="N" Type="Geographic">Malaysia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">autoimmune diseases</Keyword><Keyword MajorTopicYN="N">genetic</Keyword><Keyword MajorTopicYN="N">polymorphism</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>2</Day><Hour>5</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35105721</ArticleId><ArticleId IdType="pmc">PMC8808435</ArticleId><ArticleId IdType="doi">10.1136/lupus-2021-000554</ArticleId><ArticleId IdType="pii">9/1/e000554</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Choi MY, Flood K, Bernatsky S, et al. . A review on SLE and malignancy. Best Pract Res Clin Rheumatol 2017;31:373&#x2013;96. 10.1016/j.berh.2017.09.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.berh.2017.09.013</ArticleId><ArticleId IdType="pmc">PMC6742439</ArticleId><ArticleId IdType="pubmed">29224679</ArticleId></ArticleIdList></Reference><Reference><Citation>Justiz Vaillant AA, Goyal A, Bansal P. Systemic lupus erythematosus. Treasure Island, FL: StatPearls, 2021.</Citation></Reference><Reference><Citation>Gergianaki I, Bortoluzzi A, Bertsias G. Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2018;32:188&#x2013;205. 10.1016/j.berh.2018.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.berh.2018.09.004</ArticleId><ArticleId IdType="pubmed">30527426</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Estel GJ, Ugarte-Gil MF, Alarc&#xf3;n GS. Epidemiology of systemic lupus erythematosus. Expert Rev Clin Immunol 2017;13:799&#x2013;814. 10.1080/1744666X.2017.1327352</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2017.1327352</ArticleId><ArticleId IdType="pubmed">28471259</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Wang CL, Tan CT, et al. . Systemic lupus erythematosus in Malaysia: a study of 539 patients and comparison of prevalence and disease expression in different racial and gender groups. Lupus 1997;6:248&#x2013;53. 10.1177/096120339700600306</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/096120339700600306</ArticleId><ArticleId IdType="pubmed">9104731</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo C-F, Grainge MJ, Valdes AM, et al. . Familial aggregation of systemic lupus erythematosus and coaggregation of autoimmune diseases in affected families. JAMA Intern Med 2015;175:1518&#x2013;26. 10.1001/jamainternmed.2015.3528</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2015.3528</ArticleId><ArticleId IdType="pubmed">26193127</ArticleId></ArticleIdList></Reference><Reference><Citation>Gough SCL, Simmonds MJ. The HLA region and autoimmune disease: associations and mechanisms of action. Curr Genomics 2007;8:453&#x2013;65. 10.2174/138920207783591690</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138920207783591690</ArticleId><ArticleId IdType="pmc">PMC2647156</ArticleId><ArticleId IdType="pubmed">19412418</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghodke-Puranik Y, Niewold TB. Immunogenetics of systemic lupus erythematosus: a comprehensive review. J Autoimmun 2015;64:125&#x2013;36. 10.1016/j.jaut.2015.08.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2015.08.004</ArticleId><ArticleId IdType="pmc">PMC4628859</ArticleId><ArticleId IdType="pubmed">26324017</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchini M, Antonioli R, Lle&#xf2; A, et al. . Hla class II antigens associated with lupus nephritis in Italian SLE patients. Hum Immunol 2003;64:462&#x2013;8. 10.1016/S0198-8859(03)00017-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0198-8859(03)00017-X</ArticleId><ArticleId IdType="pubmed">12651073</ArticleId></ArticleIdList></Reference><Reference><Citation>McHugh NJ, Owen P, Cox B, et al. . Mhc class II, tumour necrosis factor alpha, and lymphotoxin alpha gene haplotype associations with serological subsets of systemic lupus erythematosus. Ann Rheum Dis 2006;65:488&#x2013;94. 10.1136/ard.2005.039842</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2005.039842</ArticleId><ArticleId IdType="pmc">PMC1798099</ArticleId><ArticleId IdType="pubmed">16107511</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundstr&#xf6;m E, Gustafsson JT, J&#xf6;nsen A, et al. . HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus. Ann Rheum Dis 2013;72:1018&#x2013;25. 10.1136/annrheumdis-2012-201760</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2012-201760</ArticleId><ArticleId IdType="pubmed">22893315</ArticleId></ArticleIdList></Reference><Reference><Citation>Bettencourt A, Carvalho C, Leal B, et al. . The Protective Role of HLA-DRB1(&#x2217;)13 in Autoimmune Diseases. J Immunol Res 2015;2015:948723. 10.1155/2015/948723</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/948723</ArticleId><ArticleId IdType="pmc">PMC4641944</ArticleId><ArticleId IdType="pubmed">26605347</ArticleId></ArticleIdList></Reference><Reference><Citation>Hachicha H, Kammoun A, Mahfoudh N, et al. . Human leukocyte antigens-DRB1*03 is associated with systemic lupus erythematosus and anti-SSB production in South Tunisia. Int J Health Sci 2018;12:21&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5870315</ArticleId><ArticleId IdType="pubmed">29623013</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan CF, Wu CJ, Chen HH, et al. . Molecular analysis of HLA-DRB1 allelic associations with systemic lupus Erythematous and lupus nephritis in Taiwan. Lupus 2009;18:698&#x2013;704. 10.1177/0961203308101955</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203308101955</ArticleId><ArticleId IdType="pubmed">19502265</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa H, Kawasaki A, Oka S, et al. . Human leukocyte antigens and systemic lupus erythematosus: a protective role for the HLA-DR6 alleles DRB1*13:02 and *14:03. PLoS One 2014;9:e87792. 10.1371/journal.pone.0087792</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0087792</ArticleId><ArticleId IdType="pmc">PMC3912000</ArticleId><ArticleId IdType="pubmed">24498373</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang S-Y, Choi J-Y, Park S, et al. . Brief report: influence of HLA-DRB1 susceptibility alleles on the clinical subphenotypes of systemic lupus erythematosus in Koreans. Arthritis Rheumatol 2016;68:1190&#x2013;6. 10.1002/art.39539</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39539</ArticleId><ArticleId IdType="pubmed">26663868</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Yang C, Fei W, et al. . HLA-DQ&#x3b2;1 amino acid position 87 and DQB1*0301 are associated with Chinese Han SLE. Mol Genet Genomic Med 2018;6:541&#x2013;6. 10.1002/mgg3.403</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mgg3.403</ArticleId><ArticleId IdType="pmc">PMC6081216</ArticleId><ArticleId IdType="pubmed">29676044</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirikong M, Tsuchiya N, Chandanayingyong D, et al. . Association of HLA-DRB1*1502-DQB1*0501 haplotype with susceptibility to systemic lupus erythematosus in Thais. Tissue Antigens 2002;59:113&#x2013;7. 10.1034/j.1399-0039.2002.590206.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-0039.2002.590206.x</ArticleId><ArticleId IdType="pubmed">12028537</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong NC, Nasruruddin BA, Murad S, et al. . Hla antigens in Malay patients with systemic lupus erythematosus. Lupus 1994;3:393&#x2013;5. 10.1177/096120339400300505</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/096120339400300505</ArticleId><ArticleId IdType="pubmed">7841992</ArticleId></ArticleIdList></Reference><Reference><Citation>Azizah MR, Ainol SS, Kong NC, et al. . Hla antigens in Malay patients with systemic lupus erythematosus: association with clinical and autoantibody expression. Korean J Intern Med 2001;16:123&#x2013;31. 10.3904/kjim.2001.16.2.123</Citation><ArticleIdList><ArticleId IdType="doi">10.3904/kjim.2001.16.2.123</ArticleId><ArticleId IdType="pmc">PMC4531713</ArticleId><ArticleId IdType="pubmed">11590899</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohd-Yusuf Y, Phipps ME, Chow SK, et al. . HLA-A*11 and novel associations in Malays and Chinese with systemic lupus erythematosus. Immunol Lett 2011;139:68&#x2013;72. 10.1016/j.imlet.2011.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2011.05.001</ArticleId><ArticleId IdType="pubmed">21658414</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvaraja M, Chin VK, Abdullah M, et al. . HLA-DRB1*04 as a Risk Allele to Systemic Lupus Erythematosus and Lupus Nephritis in the Malay Population of Malaysia. Front Med 2020;7:598665. 10.3389/fmed.2020.598665</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.598665</ArticleId><ArticleId IdType="pmc">PMC7902771</ArticleId><ArticleId IdType="pubmed">33644084</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan L-K, Mohd-Farid B, Salsabil S, et al. . Hla-A, -B, -C, -DRB1 and -DQB1 alleles and haplotypes in 951 Southeast Asia Malays from Peninsular Malaysia. Hum Immunol 2016;77:818&#x2013;9. 10.1016/j.humimm.2016.06.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2016.06.022</ArticleId><ArticleId IdType="pubmed">27370684</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American College of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725. 10.1002/art.1780400928</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400928</ArticleId><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Chun-Lai T, Padyukov L, Dhaliwal JS, et al. . Shared epitope alleles remain a risk factor for anti-citrullinated proteins antibody (ACPA)--positive rheumatoid arthritis in three Asian ethnic groups. PLoS One 2011;6:e21069. 10.1371/journal.pone.0021069</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0021069</ArticleId><ArticleId IdType="pmc">PMC3115981</ArticleId><ArticleId IdType="pubmed">21698259</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan LK, Too CL, Diaz-Gallo LM, et al. . The spectrum of association in HLA region with rheumatoid arthritis in a diverse Asian population: evidence from the MyEIRA case-control study. Arthritis Res Ther 2021;23:46. 10.1186/s13075-021-02431-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-021-02431-z</ArticleId><ArticleId IdType="pmc">PMC7847037</ArticleId><ArticleId IdType="pubmed">33514426</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia X, Han B, Onengut-Gumuscu S, et al. . Imputing amino acid polymorphisms in human leukocyte antigens. PLoS One 2013;8:e64683. 10.1371/journal.pone.0064683</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0064683</ArticleId><ArticleId IdType="pmc">PMC3675122</ArticleId><ArticleId IdType="pubmed">23762245</ArticleId></ArticleIdList></Reference><Reference><Citation>Excoffier L, Lischer HEL. Arlequin suite VER 3.5: a new series of programs to perform population genetics analyses under Linux and windows. Mol Ecol Resour 2010;10:564&#x2013;7. 10.1111/j.1755-0998.2010.02847.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1755-0998.2010.02847.x</ArticleId><ArticleId IdType="pubmed">21565059</ArticleId></ArticleIdList></Reference><Reference><Citation>Endreffy E, Kov&#xe1;cs A, Kov&#xe1;cs L, et al. . Hla class II allele polymorphism in Hungarian patients with systemic lupus erythematosus. Ann Rheum Dis 2003;62:1017&#x2013;8. 10.1136/ard.62.10.1017</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.62.10.1017</ArticleId><ArticleId IdType="pmc">PMC1754336</ArticleId><ArticleId IdType="pubmed">12972487</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramal LM, L&#xf3;pez-Nevot MA, Sabio JM, et al. . Systemic lupus erythematosus in southern Spain: a comparative clinical and genetic study between Caucasian and gypsy patients. Lupus 2004;13:934&#x2013;40. 10.1191/0961203304lu2036oa</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/0961203304lu2036oa</ArticleId><ArticleId IdType="pubmed">15645749</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong DL, Zidovetzki R, Alarc&#xf3;n-Riquelme ME, et al. . Gwas identifies novel SLE susceptibility genes and explains the association of the HLA region. Genes Immun 2014;15:347&#x2013;54. 10.1038/gene.2014.23</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gene.2014.23</ArticleId><ArticleId IdType="pmc">PMC4156543</ArticleId><ArticleId IdType="pubmed">24871463</ArticleId></ArticleIdList></Reference><Reference><Citation>Fl&#xe5;m ST, Gunnarsson R, Garen T, et al. . The HLA profiles of mixed connective tissue disease differ distinctly from the profiles of clinically related connective tissue diseases. Rheumatology 2015;54:528&#x2013;35. 10.1093/rheumatology/keu310</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keu310</ArticleId><ArticleId IdType="pubmed">25187641</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas-Alarc&#xf3;n G, Salgado N, Granados J, et al. . Class II allele and haplotype frequencies in Mexican systemic lupus erythematosus patients: the relevance of considering homologous chromosomes in determining susceptibility. Hum Immunol 2001;62:814&#x2013;20. 10.1016/S0198-8859(01)00267-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0198-8859(01)00267-1</ArticleId><ArticleId IdType="pubmed">11476905</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes LM, Baltazar LM, Lopez-Cardona MG, et al. . Hla class II haplotypes in Mexican systemic lupus erythematosus patients. Hum Immunol 2004;65:1469&#x2013;76. 10.1016/j.humimm.2004.09.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2004.09.008</ArticleId><ArticleId IdType="pubmed">15603875</ArticleId></ArticleIdList></Reference><Reference><Citation>de Holanda MI, Klumb E, Imada A, et al. . The prevalence of HLA alleles in a lupus nephritis population. Transpl Immunol 2018;47:37&#x2013;43. 10.1016/j.trim.2018.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trim.2018.02.001</ArticleId><ArticleId IdType="pubmed">29421495</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhallil O, Ibrahimi A, Ouadghiri S, et al. . Hla class II with lupus nephritis in Moroccan patients. Immunol Invest 2017;46:1&#x2013;9. 10.1080/08820139.2016.1208218</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08820139.2016.1208218</ArticleId><ArticleId IdType="pubmed">27611588</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayed K, Gorgi Y, Ayed-Jendoubi S, et al. . The involvement of HLA -DRB1*, DQA1*, DQB1* and complement C4A loci in diagnosing systemic lupus erythematosus among Tunisians. Ann Saudi Med 2004;24:31&#x2013;5. 10.5144/0256-4947.2004.31</Citation><ArticleIdList><ArticleId IdType="doi">10.5144/0256-4947.2004.31</ArticleId><ArticleId IdType="pmc">PMC6147822</ArticleId><ArticleId IdType="pubmed">15310011</ArticleId></ArticleIdList></Reference><Reference><Citation>Dedhia L, Pradhan V, Ghosh K, et al. . Association of human leucocyte antigen (HLA) class II with systemic lupus erythematosis (SLE) patients from Western India. Meta Gene 2018;16:230&#x2013;3. 10.1016/j.mgene.2018.03.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mgene.2018.03.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Katkam SK, Rajasekhar L, Kutala VK. The influence of functional polymorphic positions of HLA-DR&#x3b2;1 molecules on risk for South Indian systemic lupus erythematosus patients. Lupus 2018;27:991&#x2013;1000. 10.1177/0961203318759200</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203318759200</ArticleId><ArticleId IdType="pubmed">29439646</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu LY, Ding WZ, Fici D, et al. . Molecular analysis of major histocompatibility complex allelic associations with systemic lupus erythematosus in Taiwan. Arthritis Rheum 1997;40:1138&#x2013;45. 10.1002/art.1780400619</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400619</ArticleId><ArticleId IdType="pubmed">9182925</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimane K, Kochi Y, Suzuki A, et al. . An association analysis of HLA-DRB1 with systemic lupus erythematosus and rheumatoid arthritis in a Japanese population: effects of *09:01 allele on disease phenotypes. Rheumatology 2013;52:1172&#x2013;82. 10.1093/rheumatology/kes427</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kes427</ArticleId><ArticleId IdType="pubmed">23407388</ArticleId></ArticleIdList></Reference><Reference><Citation>Louthrenoo W, Kasitanon N, Wichainun R, et al. . The genetic contribution of HLA-DRB5*01:01 to systemic lupus erythematosus in Thailand. Int J Immunogenet 2013;40:126&#x2013;30. 10.1111/j.1744-313X.2012.01145.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1744-313X.2012.01145.x</ArticleId><ArticleId IdType="pubmed">22862923</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Motwee S, Jawdat D, Jehani GS, et al. . Association of HLA-DRB1*15 and HLADQB1*06 with SLE in Saudis. Ann Saudi Med 2013;33:229&#x2013;34. 10.5144/0256-4947.2013.229</Citation><ArticleIdList><ArticleId IdType="doi">10.5144/0256-4947.2013.229</ArticleId><ArticleId IdType="pmc">PMC6078530</ArticleId><ArticleId IdType="pubmed">23793423</ArticleId></ArticleIdList></Reference><Reference><Citation>Pillai NE, Okada Y, Saw W-Y, et al. . Predicting HLA alleles from high-resolution SNP data in three Southeast Asian populations. Hum Mol Genet 2014;23:4443&#x2013;51. 10.1093/hmg/ddu149</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu149</ArticleId><ArticleId IdType="pubmed">24698974</ArticleId></ArticleIdList></Reference><Reference><Citation>Mark SJ, Erlich HA. 13th International Histocompatibility Workshop Anthropology/Human Genetic Diversity Joint Report - Chapter 3: Population Reports: Population Chinese, Malay and Thai from Singapore. In: Hansen J, ed. Immonobiology of the human MHC: proceedings of the 13th international histocompatibility workshop and conference. Seattle: IHWG Press, 2006: 36&#x2013;7.</Citation></Reference><Reference><Citation>Goldberg MA, Arnett FC, Bias WB, et al. . Histocompatibility antigens in systemic lupus erythematosus. Arthritis Rheum 1976;19:129&#x2013;32. 10.1002/art.1780190201</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780190201</ArticleId><ArticleId IdType="pubmed">1259797</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones EY, Fugger L, Strominger JL, et al. . Mhc class II proteins and disease: a structural perspective. Nat Rev Immunol 2006;6:271&#x2013;82. 10.1038/nri1805</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1805</ArticleId><ArticleId IdType="pubmed">16557259</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanscombe KB, Morris DL, Noble JA, et al. . Genetic fine mapping of systemic lupus erythematosus MHC associations in Europeans and African Americans. Hum Mol Genet 2018;27:3813&#x2013;24. 10.1093/hmg/ddy280</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy280</ArticleId><ArticleId IdType="pmc">PMC6196648</ArticleId><ArticleId IdType="pubmed">30085094</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>